John A Stalfort Iii Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

John A Stalfort Iii is Director of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 185,124 shares of ABOS, which is worth approximately $222,148. The most recent transaction as insider was on Jun 04, 2025, when has been sold 12,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 185K

7.43% 3M change

7.43% 12M change

Total Value Held $222,148

John A Stalfort III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 04 2025	BUY Grant, award, or other acquisition	-	12,800 Added 6.47%	185,124 Common Stock
Jul 06 2021	BUY Open market or private purchase	$560,000 $16.0 p/Share	35,000 Added 16.88%	172,324 Common Stock
Jul 06 2021	BUY Conversion of derivative security	-	130,180 Added 48.66%	137,324 Common Stock

Also insider at

VRCA

Verrica Pharmaceuticals Inc. Healthcare

TSHA

Taysha Gene Therapies, Inc. Healthcare

JAS